Cargando…
Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153526/ https://www.ncbi.nlm.nih.gov/pubmed/36519330 http://dx.doi.org/10.3324/haematol.2022.282019 |
| _version_ | 1785035946214817792 |
|---|---|
| author | Gangat, Naseema Ilyas, Rimal McCullough, Kristen Begna, Kebede H. Al-Kali, Aref Patnaik, Mrinal M. Litzow, Mark R. Hogan, William J. Mangaonkar, Abhishek Alkhateeb, Hassan Shah, Mithun V. Elliott, Michelle A. Foran, James M. Badar, Talha Palmer, Jeanne M. Hanson, Curtis A. Pardanani, Animesh Tefferi, Ayalew |
| author_facet | Gangat, Naseema Ilyas, Rimal McCullough, Kristen Begna, Kebede H. Al-Kali, Aref Patnaik, Mrinal M. Litzow, Mark R. Hogan, William J. Mangaonkar, Abhishek Alkhateeb, Hassan Shah, Mithun V. Elliott, Michelle A. Foran, James M. Badar, Talha Palmer, Jeanne M. Hanson, Curtis A. Pardanani, Animesh Tefferi, Ayalew |
| author_sort | Gangat, Naseema |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10153526 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101535262023-05-03 Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm Gangat, Naseema Ilyas, Rimal McCullough, Kristen Begna, Kebede H. Al-Kali, Aref Patnaik, Mrinal M. Litzow, Mark R. Hogan, William J. Mangaonkar, Abhishek Alkhateeb, Hassan Shah, Mithun V. Elliott, Michelle A. Foran, James M. Badar, Talha Palmer, Jeanne M. Hanson, Curtis A. Pardanani, Animesh Tefferi, Ayalew Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-12-15 /pmc/articles/PMC10153526/ /pubmed/36519330 http://dx.doi.org/10.3324/haematol.2022.282019 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Gangat, Naseema Ilyas, Rimal McCullough, Kristen Begna, Kebede H. Al-Kali, Aref Patnaik, Mrinal M. Litzow, Mark R. Hogan, William J. Mangaonkar, Abhishek Alkhateeb, Hassan Shah, Mithun V. Elliott, Michelle A. Foran, James M. Badar, Talha Palmer, Jeanne M. Hanson, Curtis A. Pardanani, Animesh Tefferi, Ayalew Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm |
| title | Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm |
| title_full | Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm |
| title_fullStr | Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm |
| title_full_unstemmed | Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm |
| title_short | Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm |
| title_sort | predictors of response to venetoclax plus hypomethylating agent therapy and survival in blast-phase myeloproliferative neoplasm |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153526/ https://www.ncbi.nlm.nih.gov/pubmed/36519330 http://dx.doi.org/10.3324/haematol.2022.282019 |
| work_keys_str_mv | AT gangatnaseema predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT ilyasrimal predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT mcculloughkristen predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT begnakebedeh predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT alkaliaref predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT patnaikmrinalm predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT litzowmarkr predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT hoganwilliamj predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT mangaonkarabhishek predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT alkhateebhassan predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT shahmithunv predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT elliottmichellea predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT foranjamesm predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT badartalha predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT palmerjeannem predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT hansoncurtisa predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT pardananianimesh predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm AT tefferiayalew predictorsofresponsetovenetoclaxplushypomethylatingagenttherapyandsurvivalinblastphasemyeloproliferativeneoplasm |